EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Eurazeo SE (0HZC) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Eurazeo SE €5.26, price €44.93, upside -88.3%, quality 40 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Financial Services · GB · Home France · ISIN FR0000121121

ES Some data Sep 24, 2026

Eurazeo SE

0HZC · LSE

Weakest SetupStrongly overvalued and low quality.

!Fair value €5.26 · Strongly overvalued (−88.3%)
!Quality 40/100
!Mixed Growth (revenue 3y +2.1 %/yr)
!Loss-making · -4.4% net margin (FY2020)
!Moderate debt
·6.5% dividend yield · Safety not assessed
!Narrow moat 1/100
!Evidence only medium, so the estimate is less certain
!The models disagree: range €5.26 to €13.73

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€75.35 €35.37 Fair Value €5.26 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range €35.37 – €75.35 · fair‑value band €5.26 – €13.73 · the €44.93 price screens above the €5.26 fair value. Dashed = 300-day average. As of Sep 24, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments.

Show more

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, digital health, life science, tech, financial services, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in New York, United States, Paris, France, Italy, North America, China and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) and"100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the

Stock analysis

Eurazeo SE (0HZC) currently trades at €44.93, while our model-based Fair Value estimate is €5.26, 88.3% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of €25.68 per share, and 0 of the 4 models we run sit above the €44.93 price.

Bear case: the Growth DCF group reads lowest at €9.45, and 4 of the 4 models stay below the price. Evidence for this calculation is medium.

Scenario range: €5.26 (bear) to €13.73 (bull), the price of €44.93 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 40/100 (below-average quality), in the Financial Services sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Eurazeo SE reported revenue of €3.7B in FY2020 versus €2.2B in FY2016, a compound +13.8%/yr. Reported net income was −€160M in FY2020.

Key figures

Market cap €5.5B · Dividend yield 6.5% · Net margin −4.4% · Return on equity −5.9% · Return on assets (EBIT) 3.7% · Operating margin −32.4% · Revenue growth (YoY) −39.2% · EPS growth (YoY) −95.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 22% below its 52-week high and 27% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −15% fair-value upside, at −88%, 0HZC screens richer than that median.

Fair Value models

Bear €5.26 Fair Value €5.26 Bull €13.73
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Growth DCF €0.8900 €9.45 €20.76 66
Gordon GGM €16.69 €30.35 €47.84 64
DDM Multi-Stage €16.69 €24.86 €33.36 64
All 4 models by family
Dividend Discount
Gordon GGM €16.69 €30.35 €47.84 64
DDM Multi-Stage €16.69 €24.86 €33.36 64
Asset-Based
NCAV (Graham) €19.17 €25.68 €38.34 54
Growth DCF
Growth DCF €0.8900 €9.45 €20.76 66

Open the full fair value analysis →

Notify me when 0HZC reaches fair value

Put 0HZC on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 40/100

Of which business quality 44 · Market factors (momentum, volatility) 45

Profitability 12
Margins and returns on capital today
Quality Growth 34
Are margins and returns improving?
Cashflow 67
Earnings quality: real cash, not paper profit
Fin. Strength 33
Balance sheet, leverage, solvency risk
Investment 90
Disciplined investing over empire-building
Low Volatility 58
Calm price path (market factor)
Momentum 46
Price trend over the last 3–12 months (market factor)
52W Momentum 28
Distance to the 52-week high (market factor)

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 20/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−21.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
33.9% (2016) → 1.4% (2020)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no share-count history
not computed

0HZC screens overvalued: fair value 88% below the price. Compare with Blackstone Inc →

Compare Eurazeo SE with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Blackstone Inc BX $112.09 $52.29 −53%
KKR & Co KKR $93.18 $29.26 −69%
Brookfield Corporation BN $36.87 $13.45 −64%
Apollo Global Management, Inc APO $116.06 $197.23 +70%
State Street Corporation STT $177.78 $139.37 −22%
Ameriprise Financial, Inc AMP $494.82 $595.40 +20%
Ares Management Corporation ARES $122.01 $103.68 −15%
Northern Trust Corporation NTRS $175.73 $123.42 −30%
Raymond James Financial, Inc RJF $161.16 $317.27 +97%
Exor N.V EXO €68.10 €136.20 +100%

Explore undervalued stocks

More undervalued Financial Services stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Eurazeo SE Fair Value". https://www.fairvalue-calculator.com/stock/0HZC

Frequently asked questions

Is Eurazeo SE (0HZC) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of €5.26 versus a price of €44.93, about −88% upside (overvalued).
What is the fair value of 0HZC?
Our model-based fair value for Eurazeo SE is €5.26 (as of Sep 24, 2026), built from audited fundamentals. The current price: €44.93.
What is the quality score of 0HZC?
Eurazeo SE has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Eurazeo SE (0HZC)?
Our model-based price target is the fair value of €5.26 (as of Sep 24, 2026) from 4 valuation models. Cautious scenario €5.26, optimistic scenario €13.73. It is a calculation from audited fundamentals, not an analyst target.
What is the Eurazeo SE stock forecast for 2026?
Our models put fair value at €5.26, about −88% upside versus a price of €44.93 (overvalued). Cautious scenario €5.26, optimistic scenario €13.73. The calculation is refreshed regularly with new filings.
Does Eurazeo SE pay a dividend?
Eurazeo SE currently shows a dividend yield of about 6.50% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Eurazeo SE (0HZC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Eurazeo SE it is €5.26 per share (as of Sep 24, 2026), against a price of €44.93. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is Eurazeo SE stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0HZC trades above its calculated fair value: price €44.93, fair value €5.26, a gap of about −88% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0HZC?
No. The price is what the market pays today (€44.93); the fair value is what the company's own numbers justify (€5.26). For Eurazeo SE the two are €39.67 per share apart. That gap is exactly why we show both numbers side by side.
How much is Eurazeo SE worth?
The market values Eurazeo SE at about €5.5B (market capitalisation, as of Sep 24, 2026). Per share that is €44.93; our models calculate a fair value of €5.26 per share.
What do the bullish and bearish scenarios say about 0HZC?
Our models span a range for Eurazeo SE: cautious scenario €5.26, base €5.26, optimistic €13.73 per share (as of Sep 24, 2026, price €44.93). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is 0HZC from its 52-week high?
Eurazeo SE trades at €44.93, about 22% below its 52-week high of €57.37 and 27% above the low of €35.37 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of €5.26 is for.
Which stocks are comparable to Eurazeo SE?
From the same area (Financial Services) we also value Blackstone Inc, KKR & Co, Brookfield Corporation, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Eurazeo SE stock attractive at the current price?
The data as of Sep 24, 2026: price €44.93, calculated fair value €5.26 (−88%), Quality Score 40/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0HZC calculated?
We run Eurazeo SE through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €5.26, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Eurazeo SE itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Eurazeo SE (0HZC)?
The closing price on Oct 2, 2026 was €44.93. Our model-based fair value is €5.26, about −88% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Eurazeo SE right now?
The price sits above even our optimistic bull case (€13.73). The favourable scenario is already priced in. Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide (€5.26 to €13.73). The outcome hinges heavily on assumptions, so read the point estimate with caution. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Key figures of Eurazeo SE

How large is the market capitalisation of Eurazeo SE (0HZC)?
The market capitalisation of Eurazeo SE is €5.5B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the dividend yield of Eurazeo SE (0HZC)?
The dividend yield of Eurazeo SE is 6.5%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Eurazeo SE (0HZC)?
The net margin of Eurazeo SE is −4.4% (fiscal year 2020). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Eurazeo SE (0HZC)?
The return on equity (ROE) of Eurazeo SE is −5.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Eurazeo SE (0HZC)?
On an EBIT basis the return on assets of Eurazeo SE is 3.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Eurazeo SE (0HZC)?
The operating margin of Eurazeo SE is −32.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Eurazeo SE (0HZC)?
Revenue at Eurazeo SE is growing −39.2% versus a year earlier (3y avg +2.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Eurazeo SE (0HZC)?
Earnings per share at Eurazeo SE are growing −95.9% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Continue in the live analysis

Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.

Open the live analysis →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.